These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9873570)

  • 1. Naphthoquinone analogs as inactivators of cdc25 phosphatase.
    Ham SW; Park J; Lee SJ; Kim W; Kang K; Choi KH
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2507-10. PubMed ID: 9873570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
    Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
    Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
    Schepetkin IA; Karpenko AS; Khlebnikov AI; Shibinska MO; Levandovskiy IA; Kirpotina LN; Danilenko NV; Quinn MT
    Eur J Med Chem; 2019 Dec; 183():111719. PubMed ID: 31563013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases.
    Wipf P; Aslan DC; Southwick EC; Lazo JS
    Bioorg Med Chem Lett; 2001 Feb; 11(3):313-7. PubMed ID: 11212099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
    Cao S; Murphy BT; Foster C; Lazo JS; Kingston DG
    Bioorg Med Chem; 2009 Mar; 17(6):2276-81. PubMed ID: 19028102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase.
    Wu FY; Sun TP
    Eur J Cancer; 1999 Sep; 35(9):1388-93. PubMed ID: 10658532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated NSC as a Cdc25 inhibitor.
    Park H; Carr BI; Li M; Ham SW
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2351-4. PubMed ID: 17379514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CDC25A and CDC25B in head and neck cancers.
    Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
    Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of some new substituted quinolin-4-one and 1,7-naphthyridin-4-one analogs.
    el-Subbagh HI; Abadi AH; al-Khawad IE; al-Rashood KA
    Arch Pharm (Weinheim); 1999 Jan; 332(1):19-24. PubMed ID: 10073140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
    Kar S; Wang M; Ham SW; Carr BI
    Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.
    Tamura K; Southwick EC; Kerns J; Rosi K; Carr BI; Wilcox C; Lazo JS
    Cancer Res; 2000 Mar; 60(5):1317-25. PubMed ID: 10728693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
    Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
    Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression.
    Kabakci Z; Käppeli S; Cantù C; Jensen LD; König C; Toggweiler J; Gentili C; Ribaudo G; Zagotto G; Basler K; Pinna LA; Cozza G; Ferrari S
    Sci Rep; 2019 Feb; 9(1):1335. PubMed ID: 30718768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
    Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI
    Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
    Kar S; Wang M; Ham SW; Carr BI
    Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
    Wu W; Fan YH; Kemp BL; Walsh G; Mao L
    Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.